Philstar.com on MSN
2 PMA cadets graduate from Japan defense school
MANILA, Philippines — Two cadets of the Philippine Military Academy (PMA) have graduated from the Japan National Defense ...
JNDA submission supported by results of Japanese and global phase 2 clinical trials evaluating epcoritamab in patients with mature B-cell non-Hodgkin’s lymphoma (NHL), including relapsed/refractory ...
JNDA Submission Represents First Regulatory Submission for Marketing Approval of Vadadustat CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Akebia Therapeutics, Inc. (Nasdaq: AKBA), today announced that ...
(RTTNews) - Genmab A/S (GMAB) announced Wednesday that the company has submitted a Japan new drug application (JNDA) to the Ministry of Health, Labor and Welfare (MHLW) of Japan for subcutaneous ...
GSK has submitted a Japanese New Drug Application (JNDA) for its oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), daprodustat. GlaxoSmithKline (GSK) has submitted a Japanese New ...
COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB): JNDA submission supported by results of Japanese and global phase 2 clinical trials evaluating epcoritamab in patients with mature ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results